Large B-Cell Lymphoma Real-World Data
Large B-Cell Lymphoma (LBCL) In the United States alone, between 18,000 and 25,000 new cases are diagnosed every year.
Qdata® can help lead to better treatments.
Qdata® Large B-Cell Lymphoma is an exclusive dataset providing a clear view of treatment decisions across lines of therapy, including use of CAR-T and other advanced therapies, with longitudinal outcome data.
Key Data Elements
Demographics
Molecular Markers
Double-Hit & Triple-Hit
Performance Status
CAR-T Cell Therapy
Autologous Transplant
BCL-2/BTK Inhibitors
Relapsed/Refractory
Lines of Therapy
Survival & Outcomes
About Qdata® Large B-Cell Lymphoma
LBCL is a fast-growing, aggressive type of blood cancer that develops in the lymphatic system. It is the most common form of non-Hodgkin lymphoma worldwide, accounting for about one in three cases. While it is aggressive, it often responds very well to treatment and is frequently curable.
LBCL medical research is aided by deeply abstracted, longitudinal LBCL patient records that capture clinical detail required to understand disease biology and treatment response. The dataset includes molecular subtyping, double hit and triple hit classification, CAR T therapy history, and detailed multi line treatment sequencing. Each record is curated under oncology oversight and structured to support regulatory and development use.
The LBCL dataset maintains high completeness across the clinical variables that drive decision-making, including molecular subtype, performance status, treatment intent, and documented outcomes.
Evidence in Action
Comprehensive Coverage Across the Full LBCL Continuum
With 92% of patients with outcome data, 82% of patients with performance status, and 5.2 years average length of follow-up, the dataset reflects the specialized care setting central to LBCL management.
Comprehensive Coverage of LBCL Treatment Modalities
The LBCL dataset reflects the full treatment landscape, from frontline chemoimmunotherapy to transplant and advanced cellular therapies. Each line of therapy is documented in sequence, with detailed response and outcome capture across care settings.
Custom Data Curation
Need data tailored to your exact study design requirements?
Our purpose-built, fit-for-purpose datasets are designed to support rigorous research and confident decision-making. These datasets can be tailored
around custom inclusion and exclusion criteria, in addition to including all standard abstracted data elements.
Agent Claire for Life Sciences
Expedite and streamline R&D tasks
Agent Claire for Life Sciences enables researchers to rapidly generate analytic insights. Researchers can query the rich real-world datasets using conversational questions that range in sophistication. With Agent Claire for Life Sciences, researchers have immediate, direct access to extensive data, without needing SQL skills or analyst assistance. Beyond timesavings benefits, agent Claire provides high transparency to ensure scientific rigor.
Ready to Explore the Large B-Cell Lymphoma Dataset?
Connect with our team to discuss your research objectives and receive a tailored data overview.